Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences.
Lietke S, Schmutzer M, Schwartz C, Weller J, Siller S, Aumiller M, Heckl C, Forbrig R, Niyazi M, Egensperger R, Stepp H, Sroka R, Tonn JC, Rühm A, Thon N. Lietke S, et al. Among authors: egensperger r. Cancers (Basel). 2021 Apr 7;13(8):1767. doi: 10.3390/cancers13081767. Cancers (Basel). 2021. PMID: 33917116 Free PMC article.
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.
Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, Pöpperl G, Kretzschmar HA, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C, Thon N. Jansen NL, et al. Among authors: egensperger r. Neuro Oncol. 2012 Dec;14(12):1473-80. doi: 10.1093/neuonc/nos259. Epub 2012 Oct 22. Neuro Oncol. 2012. PMID: 23090986 Free PMC article.
Dynamic 18F-FET PET is a powerful imaging biomarker in gadolinium-negative gliomas.
Kunz M, Albert NL, Unterrainer M, la Fougere C, Egensperger R, Schüller U, Lutz J, Kreth S, Tonn JC, Kreth FW, Thon N. Kunz M, et al. Among authors: egensperger r. Neuro Oncol. 2019 Feb 14;21(2):274-284. doi: 10.1093/neuonc/noy098. Neuro Oncol. 2019. PMID: 29893965 Free PMC article. Clinical Trial.
Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I.
Biczok A, Karschnia P, Vitalini R, Lenski M, Greve T, Thorsteinsdottir J, Egensperger R, Dorn F, Tonn JC, Schichor C. Biczok A, et al. Among authors: egensperger r. Acta Neurochir (Wien). 2021 Oct;163(10):2853-2859. doi: 10.1007/s00701-021-04780-9. Epub 2021 Mar 5. Acta Neurochir (Wien). 2021. PMID: 33674888 Free PMC article.
Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses.
Thon N, Kunz M, Lemke L, Jansen NL, Eigenbrod S, Kreth S, Lutz J, Egensperger R, Giese A, Herms J, Weller M, Kretzschmar H, Tonn JC, la Fougère C, Kreth FW. Thon N, et al. Among authors: egensperger r. Int J Cancer. 2015 May 1;136(9):2132-45. doi: 10.1002/ijc.29259. Epub 2014 Nov 3. Int J Cancer. 2015. PMID: 25311315 Free article.
86 results